Protected DNA Templates for Scalable Homologous Recombination

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current genome editing technologies, such as HR, are labor-intensive, difficult to scale, and inefficient in organisms where HR is not prevalent, necessitating the development of more robust and scalable methods for genome engineering.

Innovation Solution

The use of a guide polynucleotide, a protected polynucleotide modification template, and a Cas endonuclease to modify nucleotide sequences and increase the frequency of homologous directed repair, while decreasing off-site integration of the modification template.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If traditional homologous recombination (HR) is used for genome editing, then gene modification can be achieved, but the process is labor-intensive and difficult to scale

Engineering Contradiction:
Improvegenome editing efficiencyVSAvoidprocess complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent segments the genome editing process into distinct functional components: guide RNA for target recognition, Cas endonuclease for cleavage, and protected DNA templates for repair. This segmentation enables modular optimization and simplifies the overall process while maintaining high efficiency

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent introduces protected DNA templates as intermediary molecules that mediate between the Cas endonuclease cleavage event and the final genome repair. These templates are designed with specific protective features that enable them to function as controlled intermediaries in the HR process, increasing efficiency while reducing procedural complexity

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If traditional HR methods are used in organisms where HR is not efficient, then gene modification is difficult to achieve, but increasing HR efficiency may lead to off-site integration of modification templates

Engineering Contradiction:
ImproveHR efficiencyVSAvoidoff-site integration
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent changes key parameters of the DNA template molecule itself by adding protective modifications (such as phosphorothioate bonds or hairpin structures) at the ends of the template. This parameter change enables the template to withstand cellular conditions that normally promote off-site integration, while simultaneously enhancing its ability to participate in HR at the intended target site

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent converts the potential harm of cellular mechanisms that cause off-site integration into a benefit by designing templates with protective features. These features inadvertently protect against off-site integration while promoting on-target HR, effectively turning a harmful cellular process into a selective advantage for properly designed templates

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the robustness of HR, making it more efficient and scalable, and reduces off-site integration, thereby improving the precision and effectiveness of genome editing.

Implementation Method 1

increase the frequency of homologous directed repair

Methodology Applied
Scientific EffectHomologous directed repair:

Data Source

PatentEP4144844B1Protected DNA templates for gene modification and increased homologous recombination in cells and methods of use
Publication Date: 2025.09.10 DUPONT US HOLDING LLC
  • EP4144844B1 patent drawingFigure 1
  • EP4144844B1 patent drawingFigure 2
  • EP4144844B1 patent drawingFigure 3A~3D

AI summary

Compositions and methods are provided for modifying a nucleotide sequence in the genome of a cell. The methods and compositions employ a guide polynucleotide, a protected polynucleotide modification template and a Cas endonuclease to modify a nucleotide sequence and/or to increase the frequency of homologous directed repair. The methods can further be used to decrease the frequency of off-site integration of any modification template. The present disclosure also describes methods for selecting a cell comprising a modified target site in its genome and methods for selecting a cell comprising a polynucleotide of interest inserted into a target site in its genome.